The latest Funko drop brings Snow White and the Evil Queen to you in two different stunning outfits, bringing the total to 4.

Funko is here with three new Funko Pops featuring all three Eds in their iconic outfits from the cartoon and one awesome Chase!

EVERETT, Wash. - Funko, Inc. (NASDAQ: NASDAQ:FNKO), a prominent pop culture company with a market capitalization of $754 million and impressive 76% stock return over the past year according to ...

Funko (FNKO) has teamed up with the NBA to a new option for customizing Pop! Yourself, the company’s product that allows users to create a ...

Increased total tau and phosphorylated tau species (Thr181, Ser199, Thr231) in the amygdala and hippocampus starting at three months. Spatial memory deficits starting at five months by the Morris ...

From Billy Joel’s inability to resist a good Beethoven melody to Lady Gaga’s sampling of rhapsodic violin solos, here are the greatest examples of classical samples in pop. In 19 cases of chicken and ...

From the sampled vocals of Mel & Kim to the instantly memorable lyrics of Rick Astley's biggest hits, Stock, Aitken and Waterman's songs ruled the UK charts in the late 1980s. With a blue plaque ...

SINGAPORE - K-pop girl group Apink are finally coming back to Singapore. The quintet will be holding a concert for the first time in almost nine years on Feb 20, at Singapore Expo’s Arena @ Expo ...

In recent years, the leader of DC’s collectible market has been Funko with their various Pop figures. Superman was one of the first Pops the company ever did. Now, ahead of his next big screen ...

That’s what’s been happening in Africa. Previously, the continent only had one POP through a facility in Lagos, Nigeria, which might have had limited capacity. As a result, many Starlink ...

The TP53 gene is a gene that is mutated in many cancers. It is the most common gene mutation found in cancer cells. A tumor-suppressor gene, TP53 codes for a protein that inhibits the development and ...

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and Vectibix significantly improved progression-free survival in patients with KRAS ...